|
Peter Barton Hutt has served as a member of our Board since August 2004. Mr. Hutt has been a partner or senior counsel specializing in food and drug law in the Washington D.C. law firm of Covington & Burling since 1968 except when he served as Chief Counsel for the FDA from 1971 to 1975. He is the co-author of a casebook used to teach food and drug law throughout the country and teaches a full course on this subject each year at Harvard Law School. Mr. Hutt currently serves on the board of directors of Favrille Inc. a biopharmaceutical company CV Therapeutics Inc. a biopharmaceutical company ISTA Pharmaceuticals Inc. a specialty pharmaceutical company XOMA Ltd. a biopharmaceutical company and Momenta Pharmaceuticals Inc. a biotechnology company all of which are publicly-traded companies. Mr. Hutt also serves on the board of directors of several privately-held biopharmaceutical companies and on several venture capital advisory boards including Polaris Venture Partners and the Sprout Group. Mr. Hutt is also a former member of the board of directors of IDEC Pharmaceuticals Corporation a company that pioneered monoclonal antibody based treatments for cancer and autoimmune disorders. Mr. Hutt received his B.A. in Economics and Political Science from Yale University an L.L.B. from Harvard Law School and an L.L.M. in Food and Drug Law from New York University Law School.
| 